Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Olivier Govaere.

Newcastle AuthorsTitleYearFull text
Dr Katherine Johnson
Dr Peter Leary
Dr Olivier Govaere
Dr Matthew Barter
Sarah Charlton
et al.
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance2022
Dr Olivier Govaere
Dr Rebecca Darlay
Dr Julien Peltier
Dr Jeremy Palmer
Dr Massimo Younes
et al.
Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease2022
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Caucasian Lean Subjects with Non-Alcoholic Fatty Liver Disease Share Long-Term Prognosis of Non-Lean: Time for Reappraisal of BMI-Driven Approach?2021
Dr Massimo Younes
Rachel Burgoyne
Dr Dina Tiniakos
Dr Olivier Govaere
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease2021
Marco Zaki
Dr Ahmed Mahdi
Dr Gillian Patman
Anna Whitehead
Joao Mauricio
et al.
Key features of the environment promoting liver cancer in the absence of cirrhosis2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Youssef William Zaki
et al.
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Pierre Bedossa
Dr Simon Cockell
Dr Massimo Younes
et al.
NASH limits anti-tumor surveillance in immunotherapy-treated HCC2021
Professor Ann Daly
Dr Olivier Govaere
Professor Quentin Anstee
Peptide-Based Urinary Monitoring of Fibrotic Non-Alcoholic Steatohepatitis by Mass Barcoded Activity-Based Sensors2021
Dr Olivier Govaere
Dr Simon Cockell
Professor Ann Daly
Professor Quentin Anstee
Transcriptomics Identify Thrombospondin-2 as a Biomarker for Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Fiona Oakley
Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis2020
Dr Olivier Govaere
Professor Quentin Anstee
Erratum: Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC2020
Professor Quentin Anstee
Dr Rebecca Darlay
Dr Simon Cockell
Dr Olivier Govaere
Dr Dina Tiniakos
et al.
Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort2020
Dr Olivier Govaere
Professor Quentin Anstee
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers2020
Dr Olivier Govaere
Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD)2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Luca Miele
Dr Dina Tiniakos
Professor Alastair Burt
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease2020
Dr Olivier Govaere
Dr Simon Cockell
Dr Dina Tiniakos
Dr Rachel Queen
Dr Massimo Younes
et al.
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis2020
Hannah Paish
Lee Reed
Helen Brown
Mark Bryan
Dr Olivier Govaere
et al.
A bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices2019
Professor Quentin Anstee
Professor Helen Reeves
Dr Olivier Govaere
From NASH to HCC: current concepts and future challenges2019
Dr Olivier Govaere
Dr Simon Cockell
Dr Arianna Bianchi
High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease2019
Dr Marie Boyle
Dr Dina Tiniakos
Dr Olivier Govaere
Dr Massimo Younes
Dr Stuart McPherson
et al.
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease2019
Dr Olivier Govaere
Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model2019
Dr Olivier Govaere
Misti McCain
The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers2019
Dr Olivier Govaere
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role2019
Dr Olivier Govaere
Dr Dina Tiniakos
Hepatic Progenitor Cells in Metastatic Liver Carcinomas2018
Dr Olivier Govaere
Professor Quentin Anstee
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis2018
Dr Olivier Govaere
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma2017
Dr Olivier Govaere
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching2017
Dr Olivier Govaere
Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy2017
Dr Olivier Govaere
RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers2017
Dr Olivier Govaere
The footprint of the ageing stroma in older patients with breast cancer2017
Dr Olivier Govaere
Professor Quentin Anstee
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma2017
Dr Olivier Govaere
Chemokine (C-C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury2016
Dr Olivier Govaere
Dr Sabine Klein
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis2016
Dr Olivier Govaere
Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples2016
Dr Olivier Govaere
Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease2016
Dr Olivier Govaere
Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche2016
Dr Olivier Govaere
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma2016
Dr Olivier Govaere
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry2016
Dr Olivier Govaere
Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems2016
Dr Olivier Govaere
Expression of FOXP1 and Colorectal Cancer Prognosis2015
Dr Olivier Govaere
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis2015
Dr Olivier Govaere
Pathogenesis and Prognosis of Hepatocellular Carcinoma at the Cellular and Molecular Levels2015
Dr Olivier Govaere
Pituitary tumors contain a side population with tumor stem cell-associated characteristics2015
Dr Olivier Govaere
Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure2015
Dr Olivier Govaere
A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: Identification, characterization, and prognostic value2014
Dr Olivier Govaere
Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis2014
Dr Olivier Govaere
Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals2014
Dr Olivier Govaere
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas2014